A detailed history of Newbridge Financial Services Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 535 shares of DXCM stock, worth $37,177. This represents 0.02% of its overall portfolio holdings.

Number of Shares
535
Previous 1,930 72.28%
Holding current value
$37,177
Previous $267,000 77.53%
% of portfolio
0.02%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

SELL
$110.31 - $140.45 $153,882 - $195,927
-1,395 Reduced 72.28%
535 $60,000
Q1 2024

Apr 24, 2024

SELL
$114.22 - $140.1 $129,525 - $158,873
-1,134 Reduced 37.01%
1,930 $267,000
Q4 2023

Mar 28, 2024

BUY
$75.49 - $124.16 $9,964 - $16,389
132 Added 4.5%
3,064 $380,000
Q3 2023

Oct 17, 2023

BUY
$86.06 - $137.93 $5,163 - $8,275
60 Added 2.09%
2,932 $273,000
Q2 2023

Jul 21, 2023

SELL
$112.47 - $130.98 $24,181 - $28,160
-215 Reduced 6.96%
2,872 $369,000
Q1 2023

Apr 18, 2023

SELL
$104.0 - $122.92 $20,280 - $23,969
-195 Reduced 5.94%
3,087 $358,000
Q4 2022

Jan 17, 2023

BUY
$84.98 - $122.67 $235,394 - $339,795
2,770 Added 541.02%
3,282 $0
Q2 2022

Jul 15, 2022

BUY
$67.99 - $132.89 $23,048 - $45,049
339 Added 195.95%
512 $38,000
Q1 2022

Apr 26, 2022

SELL
$94.08 - $130.2 $9,125 - $12,629
-97 Reduced 35.93%
173 $89,000
Q4 2021

Jan 19, 2022

BUY
$129.87 - $162.82 $519 - $651
4 Added 1.5%
270 $145,000
Q3 2021

Oct 27, 2021

SELL
$106.71 - $143.18 $3,308 - $4,438
-31 Reduced 10.44%
266 $145,000
Q2 2021

Sep 07, 2021

SELL
$80.99 - $107.93 $106,096 - $141,388
-1,310 Reduced 81.52%
297 $127,000
Q1 2021

Sep 07, 2021

BUY
$84.79 - $104.74 $2,713 - $3,351
32 Added 2.03%
1,607 $578,000
Q4 2020

Sep 07, 2021

BUY
$78.0 - $104.5 $25,896 - $34,694
332 Added 26.71%
1,575 $582,000
Q3 2020

Sep 07, 2021

BUY
$95.51 - $112.95 $118,718 - $140,396
1,243 New
1,243 $512,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.